(NXRT) Nexpoint Residential Trust - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US65341D1028
Stock: Multifamily, Value-Add, Apartments, Southeast, Southwest
Total Rating 30
Risk 68
Buy Signal -0.56
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.26% |
| Yield on Cost 5y | 6.03% |
| Yield CAGR 5y | 10.08% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.5% |
| Relative Tail Risk | -0.49% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.76 |
| Alpha | -30.30 |
| Character TTM | |
|---|---|
| Beta | 0.691 |
| Beta Downside | 0.814 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.30% |
| CAGR/Max DD | -0.25 |
Description: NXRT Nexpoint Residential Trust January 16, 2026
NexPoint Residential Trust, Inc. (NYSE: NXRT) is a publicly traded REIT that acquires, owns, and operates middle-income multifamily assets with “value-add” upside, primarily in large-city and suburban submarkets across the Southeast and Southwest United States. The portfolio is externally managed by NexPoint Real Estate Advisors, an affiliate of SEC-registered NexPoint Advisors, which brings deep real-estate expertise to the trust.
Key operating metrics (as of Q4 2023) show an occupancy rate near 95 % and average rent growth of roughly 4 % year-over-year, reflecting strong demand in the trust’s target regions. The weighted-average cap rate on its properties sits around 5.2 %, modestly above the industry median, indicating a slight discount to comparable assets. Macro-driven factors such as the Fed’s monetary policy stance and regional population inflows remain the primary levers of performance for this sector.
For a deeper quantitative breakdown of NXRT’s valuation metrics, you might find ValueRay’s platform useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -48.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.36 > 1.0 |
| NWC/Revenue: 7.56% < 20% (prev 27.97%; Δ -20.40% < -1%) |
| CFO/TA 0.05 > 3% & CFO 83.9m > Net Income -48.7m |
| Net Debt (1.46b) to EBITDA (200.2m): 7.28 < 3 |
| Current Ratio: 1.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.4m) vs 12m ago -0.02% < -2% |
| Gross Margin: 64.29% > 18% (prev 0.57%; Δ 6372 % > 0.5%) |
| Asset Turnover: 13.23% > 50% (prev 13.46%; Δ -0.23% > 0%) |
| Interest Coverage Ratio: 0.68 > 6 (EBITDA TTM 200.2m / Interest Expense TTM 152.4m) |
Altman Z'' 0.20
| A: 0.01 (Total Current Assets 61.4m - Total Current Liabilities 42.4m) / Total Assets 1.84b |
| B: -0.05 (Retained Earnings -99.3m / Total Assets 1.84b) |
| C: 0.05 (EBIT TTM 103.6m / Avg Total Assets 1.90b) |
| D: -0.05 (Book Value of Equity -81.2m / Total Liabilities 1.51b) |
| Altman-Z'' Score: 0.20 = B |
Beneish M -4.00
| DSRI: 0.92 (Receivables 11.2m/12.7m, Revenue 251.1m/263.0m) |
| GMI: 0.88 (GM 64.29% / 56.84%) |
| AQI: -5.94 (AQ_t -0.01 / AQ_t-1 0.00) |
| SGI: 0.95 (Revenue 251.1m / 263.0m) |
| TATA: -0.07 (NI -48.7m - CFO 83.9m) / TA 1.84b) |
| Beneish M-Score: -7.42 (Cap -4..+1) = AAA |
What is the price of NXRT shares?
As of February 08, 2026, the stock is trading at USD 30.41 with a total of 113,249 shares traded.
Over the past week, the price has changed by +0.63%, over one month by +0.07%, over three months by +0.82% and over the past year by -19.32%.
Over the past week, the price has changed by +0.63%, over one month by +0.07%, over three months by +0.82% and over the past year by -19.32%.
Is NXRT a buy, sell or hold?
Nexpoint Residential Trust has received a consensus analysts rating of 3.11.
Therefor, it is recommend to hold NXRT.
- StrongBuy: 0
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NXRT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32.8 | 7.9% |
| Analysts Target Price | 32.8 | 7.9% |
| ValueRay Target Price | 29.8 | -1.9% |
NXRT Fundamental Data Overview February 05, 2026
P/E Forward = 88.4956
P/S = 6.0659
P/B = 2.346
P/EG = -36.54
Revenue TTM = 251.1m USD
EBIT TTM = 103.6m USD
EBITDA TTM = 200.2m USD
Long Term Debt = 1.47b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 1.47b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.46b USD (from netDebt column, last quarter)
Enterprise Value = 2.99b USD (1.54b + Debt 1.47b - CCE 10.8m)
Interest Coverage Ratio = 0.68 (Ebit TTM 103.6m / Interest Expense TTM 152.4m)
EV/FCF = 35.66x (Enterprise Value 2.99b / FCF TTM 83.9m)
FCF Yield = 2.80% (FCF TTM 83.9m / Enterprise Value 2.99b)
FCF Margin = 33.43% (FCF TTM 83.9m / Revenue TTM 251.1m)
Net Margin = -19.38% (Net Income TTM -48.7m / Revenue TTM 251.1m)
Gross Margin = 64.29% ((Revenue TTM 251.1m - Cost of Revenue TTM 89.7m) / Revenue TTM)
Gross Margin QoQ = 85.50% (prev 56.41%)
Tobins Q-Ratio = 1.63 (Enterprise Value 2.99b / Total Assets 1.84b)
Interest Expense / Debt = 5.87% (Interest Expense 86.2m / Debt 1.47b)
Taxrate = 27.29% (304.0k / 1.11m)
NOPAT = 75.3m (EBIT 103.6m * (1 - 27.29%))
Current Ratio = 1.45 (Total Current Assets 61.4m / Total Current Liabilities 42.4m)
Debt / Equity = 4.55 (Debt 1.47b / totalStockholderEquity, last quarter 322.9m)
Debt / EBITDA = 7.28 (Net Debt 1.46b / EBITDA 200.2m)
Debt / FCF = 17.36 (Net Debt 1.46b / FCF TTM 83.9m)
Total Stockholder Equity = 365.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.56% (Net Income -48.7m / Total Assets 1.84b)
RoE = -13.32% (Net Income TTM -48.7m / Total Stockholder Equity 365.3m)
RoCE = 5.65% (EBIT 103.6m / Capital Employed (Equity 365.3m + L.T.Debt 1.47b))
RoIC = 4.11% (NOPAT 75.3m / Invested Capital 1.83b)
WACC = 6.41% (E(1.54b)/V(3.00b) * Re(8.46%) + D(1.47b)/V(3.00b) * Rd(5.87%) * (1-Tc(0.27)))
Discount Rate = 8.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.73%
[DCF Debug] Terminal Value 85.30% ; FCFF base≈83.1m ; Y1≈92.0m ; Y5≈119.1m
Fair Price DCF = 60.72 (EV 3.00b - Net Debt 1.46b = Equity 1.54b / Shares 25.4m; r=6.41% [WACC]; 5y FCF grow 12.20% → 2.90% )
EPS Correlation: -7.06 | EPS CAGR: 17.96% | SUE: 1.14 | # QB: 1
Revenue Correlation: -12.28 | Revenue CAGR: 1.92% | SUE: -0.18 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.36 | Chg30d=-0.020 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=-1.46 | Chg30d=-0.150 | Revisions Net=-1 | Growth EPS=-16.8% | Growth Revenue=+1.9%
P/S = 6.0659
P/B = 2.346
P/EG = -36.54
Revenue TTM = 251.1m USD
EBIT TTM = 103.6m USD
EBITDA TTM = 200.2m USD
Long Term Debt = 1.47b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 1.47b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.46b USD (from netDebt column, last quarter)
Enterprise Value = 2.99b USD (1.54b + Debt 1.47b - CCE 10.8m)
Interest Coverage Ratio = 0.68 (Ebit TTM 103.6m / Interest Expense TTM 152.4m)
EV/FCF = 35.66x (Enterprise Value 2.99b / FCF TTM 83.9m)
FCF Yield = 2.80% (FCF TTM 83.9m / Enterprise Value 2.99b)
FCF Margin = 33.43% (FCF TTM 83.9m / Revenue TTM 251.1m)
Net Margin = -19.38% (Net Income TTM -48.7m / Revenue TTM 251.1m)
Gross Margin = 64.29% ((Revenue TTM 251.1m - Cost of Revenue TTM 89.7m) / Revenue TTM)
Gross Margin QoQ = 85.50% (prev 56.41%)
Tobins Q-Ratio = 1.63 (Enterprise Value 2.99b / Total Assets 1.84b)
Interest Expense / Debt = 5.87% (Interest Expense 86.2m / Debt 1.47b)
Taxrate = 27.29% (304.0k / 1.11m)
NOPAT = 75.3m (EBIT 103.6m * (1 - 27.29%))
Current Ratio = 1.45 (Total Current Assets 61.4m / Total Current Liabilities 42.4m)
Debt / Equity = 4.55 (Debt 1.47b / totalStockholderEquity, last quarter 322.9m)
Debt / EBITDA = 7.28 (Net Debt 1.46b / EBITDA 200.2m)
Debt / FCF = 17.36 (Net Debt 1.46b / FCF TTM 83.9m)
Total Stockholder Equity = 365.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.56% (Net Income -48.7m / Total Assets 1.84b)
RoE = -13.32% (Net Income TTM -48.7m / Total Stockholder Equity 365.3m)
RoCE = 5.65% (EBIT 103.6m / Capital Employed (Equity 365.3m + L.T.Debt 1.47b))
RoIC = 4.11% (NOPAT 75.3m / Invested Capital 1.83b)
WACC = 6.41% (E(1.54b)/V(3.00b) * Re(8.46%) + D(1.47b)/V(3.00b) * Rd(5.87%) * (1-Tc(0.27)))
Discount Rate = 8.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.73%
[DCF Debug] Terminal Value 85.30% ; FCFF base≈83.1m ; Y1≈92.0m ; Y5≈119.1m
Fair Price DCF = 60.72 (EV 3.00b - Net Debt 1.46b = Equity 1.54b / Shares 25.4m; r=6.41% [WACC]; 5y FCF grow 12.20% → 2.90% )
EPS Correlation: -7.06 | EPS CAGR: 17.96% | SUE: 1.14 | # QB: 1
Revenue Correlation: -12.28 | Revenue CAGR: 1.92% | SUE: -0.18 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.36 | Chg30d=-0.020 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=-1.46 | Chg30d=-0.150 | Revisions Net=-1 | Growth EPS=-16.8% | Growth Revenue=+1.9%